Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (351-360 of 692) with videos related to

Pageof 70
Sort By:
Personalized Medicine|May 15, 2018
Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapyJustine L Kuiper, Idris Bahce, Charlotte Voorhoeve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Quantitative and Simplified Analysis of 11C-Erlotinib StudiesMaqsood Yaqub, Idris Bahce, Charlotte Voorhoeve, et al.
European Radiology|July 14, 2010
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?Joline S W Lind, Martijn R Meijerink, Anne-Marie C Dingemans, et al.
Journal of Translational Medicine|September 26, 2012
Effects of helium and air inhalation on the innate and early adaptive immune system in healthy volunteers ex vivoGezina T M L Oei, Kirsten F Smit, Djai vd Vondervoort, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2021
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer <sup>18</sup>F-FDG PET RadiomicsGuilherme D Kolinger, David Vállez García, Gerbrand Maria Kramer, et al.
Psychological Medicine|July 5, 2014
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regressionE Velthorst, M Koeter, M van der Gaag, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2013
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumorsC G Vos, M Dahele, J R van Sörnsen de Koste, et al.
Anesthesiology|December 11, 2012
Helium induces preconditioning in human endothelium in vivoKirsten F Smit, Gezina T M L Oei, Daniel Brevoord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancerAndrea Ardizzoni, Christian Manegold, Channa Debruyne, et al.
Pageof 70

Showing results (351-360 of 692) with videos related to

Sort By:
Pageof 70
Personalized Medicine|May 15, 2018
Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapyJustine L Kuiper, Idris Bahce, Charlotte Voorhoeve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Quantitative and Simplified Analysis of 11C-Erlotinib StudiesMaqsood Yaqub, Idris Bahce, Charlotte Voorhoeve, et al.
European Radiology|July 14, 2010
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?Joline S W Lind, Martijn R Meijerink, Anne-Marie C Dingemans, et al.
Journal of Translational Medicine|September 26, 2012
Effects of helium and air inhalation on the innate and early adaptive immune system in healthy volunteers ex vivoGezina T M L Oei, Kirsten F Smit, Djai vd Vondervoort, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2021
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer <sup>18</sup>F-FDG PET RadiomicsGuilherme D Kolinger, David Vállez García, Gerbrand Maria Kramer, et al.
Psychological Medicine|July 5, 2014
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regressionE Velthorst, M Koeter, M van der Gaag, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2013
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumorsC G Vos, M Dahele, J R van Sörnsen de Koste, et al.
Anesthesiology|December 11, 2012
Helium induces preconditioning in human endothelium in vivoKirsten F Smit, Gezina T M L Oei, Daniel Brevoord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancerAndrea Ardizzoni, Christian Manegold, Channa Debruyne, et al.
Pageof 70